What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

NASTAD

NASTAD's vision is a world committed to ending HIV/AIDS, viral hepatitis, and intersecting epidemics.

03/30/2026

Join us for the NMAC 2026 Biomedical HIV Prevention Summit, centered on The Syndemic Approach: Strengthening the HIV and Public Health Workforce.

This year’s theme highlights the urgent need for integrated, cross-sector solutions to complex health challenges.

Build sustainable systems, collaborate across disciplines, and drive impact in HIV prevention and care.

Register: https://www.nmac.org/bhps/

03/18/2026

Congrats to our Executive Director, Stephen Lee, on receiving the Nicholas Rango Leadership Award! ✨

Stepping into leadership at the height of the COVID-19 pandemic, Stephen led with courage, compassion, and emotional intelligence, guiding NASTAD through uncertainty while positioning the organization to grow and thrive. What could have been a period of pause became one of transformation.

Under his leadership, NASTAD expanded its programs and membership and fostered a culture where staff and board voices are empowered and encouraged to lead boldly. Stephen has remained steadfast in advancing NASTAD’s core values and supporting the communities we serve.

We are grateful for his vision, resilience, and unwavering leadership—truly embodying the spirit of the Nicholas Rango Leadership Award.

03/12/2026

LinkedIn/ Facebook/ Instagram:

📣 NASTAD is hiring! Are you passionate about advancing harm reduction, HIV, and viral hepatitis public health programs across the country? Consider applying for our Associate, Drug User Health role!

🧾 This role offers an exciting opportunity to support NASTAD’s work strengthening infectious disease prevention programs nationwide. The Associate will provide administrative and logistical support for technical assistance, trainings, and grantmaking activities that support health departments and community-based organizations, including Syringe Service Providers (SSPs).

🌟 The Associate will work closely with NASTAD’s Drug User Health team to coordinate projects, track deliverables, support events and trainings, manage communications, and help ensure programs run smoothly. This role helps expand NASTAD’s capacity to strengthen public health systems and support communities across the country.

🔗 Apply: https://jobs.smartrecruiters.com/NASTAD/744000111706902-associate-drug-user-health

03/11/2026

NASTAD is proud to support the reintroduction of the PrEP Access and Coverage Act, legislation that would expand access to lifesaving HIV prevention medications and care.

Introduced by Senators Adam Schiff and Tina Smith and Representative Mark Takano, the bill would help remove barriers to HIV prevention by ensuring PrEP and related services are covered without out of pocket costs, prohibiting prior authorization requirements, and expanding access to prevention services for uninsured and underserved communities.

At a time when access to HIV prevention programs is under threat, policies that strengthen equitable access to prevention tools like PrEP and PEP are critical to ending the HIV epidemic.

Learn more here: https://www.schiff.senate.gov/news/press-releases/news-sens-schiff-smith-rep-takano-reintroduce-bill-to-expand-access-to-lifesaving-hiv-prevention-medications/

03/06/2026

NASTAD has signed onto a national statement of support for the 2026 immunization schedule from the American Academy of Pediatrics (AAP).

Vaccines keep children healthy and thriving. AAP’s immunization recommendations are grounded in the latest scientific evidence and are designed to protect children and communities from serious diseases, including hepatitis B.

We remain concerned about efforts to weaken longstanding, evidence-based vaccine recommendations, including changes affecting universal pediatric hepatitis B vaccination.

Public health policy must be rooted in science, transparency, and the protection of children’s health.

Learn more about AAP’s immunization schedule at aap.org.

03/05/2026

NASTAD is proud to endorse a resolution introduced by Rep. Mark Pocan recognizing February 28 as HIV Is Not a Crime Awareness Day.

In 2026, it should not be a crime to live with HIV. Yet 32 states still have HIV-specific exposure or transmission laws, and 28 states impose enhanced criminal penalties based solely on a person’s HIV status, despite no evidence that these laws reduce HIV transmission or increase disclosure.

Criminalization undermines public health. These outdated and stigmatizing laws can deter individuals from seeking HIV testing, prevention, and treatment services due to fear of prosecution or discrimination.

This resolution is a call to action to:
• Repeal HIV criminalization laws
• Promote science-based HIV education
• Support increased funding for prevention, treatment, and care
• Reduce stigma and discrimination

Public health works best when policy reflects science - not fear.

Read the full resolution here:https://pocan.house.gov/sites/evo-subsites/pocan.house.gov/files/evo-media-document/pocan_031_xml.pdf

02/25/2026

NASTAD’s 2026 National Ryan White HIV/AIDS Program Part B ADAP Monitoring Project Annual Report highlights the essential role ADAP plays in maintaining access to HIV treatment during periods of coverage instability.

This week’s key finding: During the Medicaid continuous coverage unwinding, ADAP absorbed a 30% increase in new client enrollments and an 11% increase in total enrollment compared to CY2022.

These findings demonstrate ADAP’s critical role as a safety net, ensuring people with HIV can maintain access to life-saving medications and care during insurance transitions.

Stay tuned as we continue sharing key insights from this year’s report.

Read the full report:
https://nastad.org/2026-rwhap-part-b-adap-monitoring-report

02/20/2026

NASTAD is pleased to announce the release of the 2026 National Ryan White HIV/AIDS Program Part B ADAP Monitoring Project Annual Report.

The report highlights the critical role AIDS Drug Assistance Programs (ADAPs) play in supporting access to HIV treatment and improving health outcomes nationwide.

One key finding: In CY2024, ADAP achieved an 87% viral suppression rate among clients served, demonstrating the program’s continued impact in ensuring access to life-saving care.

Stay tuned over the coming weeks as we highlight additional findings and insights from this year’s report.

Read the full report: https://nastad.org/2026-rwhap-part-b-adap-monitoring-report

02/12/2026

Have you checked out our latest NASTAD × RAISE webinar? 🎥

Experts from NYU School of Medicine discuss how data-driven modeling and stakeholder collaboration can help inform HIV policy decisions and improve outcomes across populations. The session highlights real-world partnerships with health jurisdictions in the U.S. and globally.

👉 View the webinar here: https://nastad.org/resources/nastad-and-raise-webinar-series

02/07/2026

🖤 Today is National Black HIV/AIDS Awareness Day.

Black communities continue to experience a disproportionate impact of the HIV epidemic in the U.S. In 2023, Black people accounted for 38% of new HIV diagnoses, yet represented only 15% of PrEP users in 2024, highlighting ongoing gaps in access to prevention and care.

Addressing these inequities requires confronting stigma, strengthening access to prevention, and investing in Black communities. Check out this graphic and the entire AIDSVu National Black HIV/AIDS Awareness Day Toolkit for data, resources, and ways to take action:
https://aidsvu.org/resources/toolkits/national-black-hiv-aids-awareness-day-toolkit-2026/

02/05/2026

NASTAD works alongside health departments and partners to strengthen HIV and hepatitis prevention, improve care delivery, and support sustainable, harm reduction–informed programs nationwide.

Explore tools, resources, and technical assistance from NASTAD:
🔗 https://nastad.org/resources

02/03/2026

The Centers for Disease Control and Prevention highlights a twice-yearly injectable PrEP option as an additional HIV prevention choice. Expanding prevention options can support adherence, reduce barriers, and help meet people where they are.

🔗 Learn more: https://www.cdc.gov/mmwr/volumes/74/wr/mm7435a1.htm

Address

444 N Capitol Street NW, Ste 339
Washington D.C., DC
20001

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Website

http://www.NASTAD.org/

Alerts

Be the first to know and let us send you an email when NASTAD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Joseph LaFleur and Associates Psychotherapy a
Telehealth & 2001 L Street NW Ste 500

Want your practice to be the top-listed Clinic in Washington D.C.?